サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1578239

アセトアミノフェンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測

Global Acetaminophen Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 222 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アセトアミノフェンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アセトアミノフェン市場の世界需要は、2023年の109億3,000万米ドルから2032年にはほぼ176億2,000万米ドルの市場規模に達すると推定され、調査期間2024-2032年のCAGRは5.45%です。

アセトアミノフェンは、疼痛緩和と発熱管理のために最も一般的に処方される鎮痛・解熱薬です。パラセタモールとしても知られています。アセトアミノフェン（パラセタモール）はコールタールから製造される鎮痛剤です。妊娠中でも授乳中でも安全に使用できるようです。この薬は、頭痛、関節炎、その他の軽い痛みの治療に使用される穏やかな鎮痛剤です。アセトアミノフェンは非ステロイド性抗炎症薬（NSAID）に分類されるが、これは炎症性の痛みを緩和するために一般的に使用されるためです。アセトアミノフェンは、錠剤、液剤、カプセルなどの形で入手できます。アセトアミノフェンは、小児や乳児を含むすべての年齢層に安全であり、一般的な成人用量は500～1000mgです。アセトアミノフェンは平均的な量であれば安全ですが、過剰に使用すると吐き気、嘔吐、発汗を起こすことがあります。重篤な皮疹はまれであるが、薬の過剰投与は肝不全を引き起こす可能性があります。アセトアミノフェンには活性代謝物のフェナセチンとアセトアニリドが含まれるが、フェナセチンとアセトアニリドとは異なり、治療用量では発がん性はないです。

市場力学

アセトアミノフェン市場は、日常的な鎮痛を必要とする慢性疾患や症状の増加により拡大しています。消費者の健康意識の高まり、染料や化学産業におけるアセトアミノフェンの用途の増加、軽度の痛みや発熱に対してアセトアミノフェンを推奨する医師の増加などが、アセトアミノフェン（パラセタモール）市場の成長を後押ししています。さらに、パラセタモール生産における技術の進歩と近代化の高まり、ヘルスケア分野における研究開発活動の活発化、老人人口が増加している新興国市場の台頭は、アセトアミノフェン（パラセタモール）市場に新たな機会をもたらすと思われます。しかし、多くのジェネリック医薬品の利用可能性の上昇、激しい競合、持続可能な化学の人気の高まりは、市場の成長を阻害し、アセトアミノフェン（パラセタモール）市場の開拓をさらに困難にする重大な要因です。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはアセトアミノフェンの世界市場における各セグメントを包括的に評価することもできます。アセトアミノフェン産業の成長と動向は、この調査に全体的なアプローチを提供します。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 アセトアミノフェン-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 アセトアミノフェンの世界市場分析：剤形別

  • 概要
  • 実績および予測データ分析
  • 錠剤
  • 液状懸濁液
  • 輸液
  • その他の剤形

第6章 アセトアミノフェンの世界市場分析：投与経路別

  • 概要
  • 実績および予測データ分析
  • 経口
  • 非経口
  • その他の投与経路

第7章 アセトアミノフェンの世界市場分析：用途別

  • 概要
  • 実績および予測データ分析
  • 鎮痛・発熱
  • 風邪
  • 頭痛
  • 腹痛

第8章 アセトアミノフェンの世界市場分析：流通チャネル別

  • 概要
  • 実績および予測データ分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 アセトアミノフェンの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 アセトアミノフェン企業の競合情勢

  • アセトアミノフェン市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Sanofi
  • Janssen Pharmaceuticals
  • Pfizer Inc.
  • Bayer AG
  • Glaxo Smithkline Pharmaceuticals Ltd
  • Granules India Limited
  • Alkem Laboratories Ltd
  • Abbott
  • Lupin Ltd
  • Teva Pharmaceuticals USA Inc.
  • BRISTOL-MYERS SQUIBB
  • B. BRAUN MELSUNGEN
  • Novartis AG
  • 10L Chemicals And Pharmaceuticals
  • Sun Pharmaceutical Industries Limited
  • Aurobindo Pharma
  • Hyloris Pharmaceuticals SA
  • Dr. Reddy'S Laboratories Ltd.
  • Mallinckrodt（Mallinckrodt Pharmaceuticals）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Dosage Form (USD MN)
  • Tablet Market Sales By Geography (USD MN)
  • Liquid Suspension Market Sales By Geography (USD MN)
  • Infusion Solution Market Sales By Geography (USD MN)
  • Other Dosage Forms Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Routes Of Administration Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Pain Relief & Fever Market Sales By Geography (USD MN)
  • Common Cold Market Sales By Geography (USD MN)
  • Headache Market Sales By Geography (USD MN)
  • Abdominal Cramps Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Acetaminophen Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Acetaminophen Report
  • Market Research Process
  • Market Research Methodology
  • Global Acetaminophen Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Dosage Form
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Dosage Form (USD MN)
  • Tablet Market Sales By Geography (USD MN)
  • Liquid Suspension Market Sales By Geography (USD MN)
  • Infusion Solution Market Sales By Geography (USD MN)
  • Other Dosage Forms Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Other Routes Of Administration Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Pain Relief & Fever Market Sales By Geography (USD MN)
  • Common Cold Market Sales By Geography (USD MN)
  • Headache Market Sales By Geography (USD MN)
  • Abdominal Cramps Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11217225

The global demand for Acetaminophen Market is presumed to reach the market size of nearly USD 17.62 Billion by 2032 from USD 10.93 Billion in 2023 with a CAGR of 5.45% under the study period 2024-2032.

Acetaminophen is the most commonly prescribed analgesic and antipyretic for pain relief and fever management. It is also known as Paracetamol. Acetaminophen (Paracetamol) is a pain reliever produced from coal tar. It appears to be safe to use both during pregnancy and when breastfeeding. The drug is a mild analgesic used to treat headaches, arthritis, and other minor aches and pains. Acetaminophen is classified as a non-steroidal anti-inflammatory drug (NSAID) because it is commonly used to alleviate inflammatory pain. Acetaminophen is available in pills, liquid solutions, and capsules, among other forms. The medicine is safe for all age groups, including children and infants, and the typical adult dose is 500 to 1000 mg. Acetaminophen is safe in average amounts, although it might cause nausea, vomiting, and sweating if used in excess. Severe skin rashes are uncommon, although excessive doses of the medication can cause liver failure. Acetaminophen contains the active metabolites phenacetin and acetanilide, but unlike phenacetin and acetanilide, it is not carcinogenic at therapeutic doses.

MARKET DYNAMICS

The acetaminophen market is growing due to the increasing number of chronic diseases and conditions requiring daily pain relief. Increasing consumer health awareness, rising acetaminophen applications in the dye and chemical industries, and increasing doctor recommendations of acetaminophen for mild pain and fever are all driving the acetaminophen (Paracetamol) market growth. Additionally, rising technological advancements and modernization in paracetamol production, rising research and development activities in the healthcare sector, and rising emerging markets with an increasing geriatric population base will create new opportunities for acetaminophen (Paracetamol) market. However, the rising availability of many generics, intense competition, and the growing popularity of sustainable chemistry are significant factors that will obstruct market growth and further challenge the development of the acetaminophen (Paracetamol) market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Acetaminophen. The growth and trends of Acetaminophen industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Acetaminophen market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Dosage Form

  • Tablet
  • Liquid Suspension
  • Infusion Solution
  • Other Dosage Forms

By Route Of Administration

  • Oral
  • Parenteral
  • Other Routes Of Administration

By Application

  • Pain Relief & Fever
  • Common Cold
  • Headache
  • Abdominal Cramps

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Global Acetaminophen Market Report market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Acetaminophen market include Sanofi, Janssen Pharmaceuticals, Pfizer Inc., Bayer AG, Glaxo Smithkline Pharmaceuticals Ltd, Granules India Limited, Alkem Laboratories Ltd, Abbott, Lupin Ltd, Teva Pharmaceuticals USA Inc., BRISTOL-MYERS SQUIBB, B. BRAUN MELSUNGEN, Novartis AG, 10L Chemicals And Pharmaceuticals, Sun Pharmaceutical Industries Limited, Aurobindo Pharma, Hyloris Pharmaceuticals SA, Dr. Reddy'S Laboratories Ltd., Mallinckrodt (Mallinckrodt Pharmaceuticals). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ACETAMINOPHEN - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Dosage Form
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACETAMINOPHEN MARKET ANALYSIS BY DOSAGE FORM

  • 5.1. Overview By Dosage Form
  • 5.2. Historical and Forecast Data Analysis By Dosage Form
  • 5.3. Tablet Historic and Forecast Sales By Regions
  • 5.4. Liquid Suspension Historic and Forecast Sales By Regions
  • 5.5. Infusion Solution Historic and Forecast Sales By Regions
  • 5.6. Other Dosage Forms Historic and Forecast Sales By Regions

6. GLOBAL ACETAMINOPHEN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route Of Administration
  • 6.2. Historical and Forecast Data Analysis By Route Of Administration
  • 6.3. Oral Historic and Forecast Sales By Regions
  • 6.4. Parenteral Historic and Forecast Sales By Regions
  • 6.5. Other Routes Of Administration Historic and Forecast Sales By Regions

7. GLOBAL ACETAMINOPHEN MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Pain Relief & Fever Historic and Forecast Sales By Regions
  • 7.4. Common Cold Historic and Forecast Sales By Regions
  • 7.5. Headache Historic and Forecast Sales By Regions
  • 7.6. Abdominal Cramps Historic and Forecast Sales By Regions

8. GLOBAL ACETAMINOPHEN MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL ACETAMINOPHEN MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ACETAMINOPHEN COMPANIES

  • 10.1. Acetaminophen Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ACETAMINOPHEN INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Sanofi
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Janssen Pharmaceuticals
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Pfizer Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Bayer AG
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Glaxo Smithkline Pharmaceuticals Ltd
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Granules India Limited
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Alkem Laboratories Ltd
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Abbott
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Lupin Ltd
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Teva Pharmaceuticals USA Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. BRISTOL-MYERS SQUIBB
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. B. BRAUN MELSUNGEN
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Novartis AG
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. 10L Chemicals And Pharmaceuticals
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Sun Pharmaceutical Industries Limited
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Aurobindo Pharma
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Hyloris Pharmaceuticals SA
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments
  • 11.20. Dr. Reddy'S Laboratories Ltd.
    • 11.20.1 Company Overview
    • 11.20.2 Company Revenue
    • 11.20.3 Products
    • 11.20.4 Recent Developments
  • 11.21. Mallinckrodt (Mallinckrodt Pharmaceuticals)
    • 11.21.1 Company Overview
    • 11.21.2 Company Revenue
    • 11.21.3 Products
    • 11.21.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies